At a glance
ClinicalIndex Comparison RecordN/ACompleted· 400 enrolled
Drug / intervention
Vitrax II +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of a New Viscoelastic for Cataract Surgery
In Brief
A clinical study evaluating Vitrax II and Viscoat for Cataract. Completed, enrolled 400 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the safety and effectiveness of a new opthalmic viscoelastic material for the use in cataract surgery. The new viscoelastic will be compared to a currently marketed viscoelastic material.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2009
Enrollment StartSep 2009
Primary CompletionNov 2010
TodayJul 2026
First PostedSep 7, 2009
Enrollment StartSep 30, 2009
Primary CompletionNov 30, 2010
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 16.8 years ago
Interventions
Vitrax IIdevice
Viscoelastic administered via one or two vials as determined by cataract surgeon for maintenance of anterior chamber.
Viscoatdevice
Currently marketed viscoelastic administered via one or two vials as determined by cataract surgeon for maintenance of anterior chamber..